[171] A 2025 observational study reported a modest increased risk of a serious eye condition in people with diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists
Indeed, GLP-1RA therapy appears to be well tolerated overall, and proportions of clinical trial participants discontinuing treatment because of adverse events tend to be low (5.49.9%) [10, 37, 39, 43, 46, 47]
Some parts of your body are more sensitive and sometimes giving [the drug] in an anatomically different site and making sure that its rotated is helpful, she says
K., Thomsen, M., Wortwein, G
This 39-amino acid peptide showed structural similarity to human GLP-1, sharing approximately 53% sequence homology
Diabetic Retinopathy Complications Inform patients to contact their physician if changes in vision are experienced during treatment with RYBELSUS [see Warnings and Precautions (5.3)]